chr18-45063305-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015559.3(SETBP1):​c.4398G>T​(p.Glu1466Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00842 in 1,604,890 control chromosomes in the GnomAD database, including 183 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1466K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0082 ( 15 hom., cov: 31)
Exomes 𝑓: 0.0084 ( 168 hom. )

Consequence

SETBP1
NM_015559.3 missense

Scores

2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.31

Publications

15 publications found
Variant links:
Genes affected
SETBP1 (HGNC:15573): (SET binding protein 1) This gene encodes a protein which contains a several motifs including a ski homology region and a SET-binding region in addition to three nuclear localization signals. The encoded protein has been shown to bind the SET nuclear oncogene which is involved in DNA replication. Mutations in this gene are associated with Schinzel-Giedion midface retraction syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
SETBP1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability, autosomal dominant 29
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Schinzel-Giedion syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • intellectual disability-expressive aphasia-facial dysmorphism syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029321015).
BP6
Variant 18-45063305-G-T is Benign according to our data. Variant chr18-45063305-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 159880.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00816 (1242/152208) while in subpopulation SAS AF = 0.0404 (195/4822). AF 95% confidence interval is 0.0358. There are 15 homozygotes in GnomAd4. There are 625 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 1242 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015559.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SETBP1
NM_015559.3
MANE Select
c.4398G>Tp.Glu1466Asp
missense
Exon 6 of 6NP_056374.2
SETBP1
NM_001379141.1
c.4398G>Tp.Glu1466Asp
missense
Exon 6 of 6NP_001366070.1
SETBP1
NM_001379142.1
c.4398G>Tp.Glu1466Asp
missense
Exon 6 of 6NP_001366071.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SETBP1
ENST00000649279.2
MANE Select
c.4398G>Tp.Glu1466Asp
missense
Exon 6 of 6ENSP00000497406.1
SETBP1
ENST00000677068.1
c.4398G>Tp.Glu1466Asp
missense
Exon 6 of 6ENSP00000504398.1
SETBP1
ENST00000677077.1
c.4398G>Tp.Glu1466Asp
missense
Exon 6 of 6ENSP00000503656.1

Frequencies

GnomAD3 genomes
AF:
0.00817
AC:
1242
AN:
152090
Hom.:
15
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00942
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00844
Gnomad ASJ
AF:
0.0130
Gnomad EAS
AF:
0.0226
Gnomad SAS
AF:
0.0404
Gnomad FIN
AF:
0.00320
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00444
Gnomad OTH
AF:
0.0106
GnomAD2 exomes
AF:
0.0115
AC:
2647
AN:
230286
AF XY:
0.0130
show subpopulations
Gnomad AFR exome
AF:
0.00945
Gnomad AMR exome
AF:
0.00651
Gnomad ASJ exome
AF:
0.0144
Gnomad EAS exome
AF:
0.0237
Gnomad FIN exome
AF:
0.00409
Gnomad NFE exome
AF:
0.00495
Gnomad OTH exome
AF:
0.0129
GnomAD4 exome
AF:
0.00845
AC:
12270
AN:
1452682
Hom.:
168
Cov.:
33
AF XY:
0.00937
AC XY:
6764
AN XY:
721860
show subpopulations
African (AFR)
AF:
0.00960
AC:
318
AN:
33138
American (AMR)
AF:
0.00658
AC:
286
AN:
43492
Ashkenazi Jewish (ASJ)
AF:
0.0131
AC:
340
AN:
25986
East Asian (EAS)
AF:
0.0187
AC:
729
AN:
39088
South Asian (SAS)
AF:
0.0399
AC:
3390
AN:
84920
European-Finnish (FIN)
AF:
0.00408
AC:
215
AN:
52664
Middle Eastern (MID)
AF:
0.0293
AC:
169
AN:
5760
European-Non Finnish (NFE)
AF:
0.00552
AC:
6112
AN:
1107548
Other (OTH)
AF:
0.0118
AC:
711
AN:
60086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
775
1550
2326
3101
3876
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
294
588
882
1176
1470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00816
AC:
1242
AN:
152208
Hom.:
15
Cov.:
31
AF XY:
0.00840
AC XY:
625
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.00939
AC:
390
AN:
41524
American (AMR)
AF:
0.00843
AC:
129
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0130
AC:
45
AN:
3466
East Asian (EAS)
AF:
0.0225
AC:
116
AN:
5166
South Asian (SAS)
AF:
0.0404
AC:
195
AN:
4822
European-Finnish (FIN)
AF:
0.00320
AC:
34
AN:
10620
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.00444
AC:
302
AN:
68000
Other (OTH)
AF:
0.0109
AC:
23
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
57
114
170
227
284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00774
Hom.:
23
Bravo
AF:
0.00910
TwinsUK
AF:
0.00782
AC:
29
ALSPAC
AF:
0.00649
AC:
25
ESP6500AA
AF:
0.00931
AC:
41
ESP6500EA
AF:
0.00512
AC:
44
ExAC
AF:
0.0114
AC:
1387
Asia WGS
AF:
0.0400
AC:
137
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 26, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27611742)

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Schinzel-Giedion syndrome Benign:2
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Jun 12, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Schinzel-Giedion syndrome;C4015141:Intellectual disability, autosomal dominant 29 Benign:1
Mar 29, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.22
T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.089
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.66
T
MetaRNN
Benign
0.0029
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.55
N
PhyloP100
2.3
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-0.52
N
REVEL
Benign
0.079
Sift
Benign
0.084
T
Sift4G
Benign
0.10
T
Polyphen
0.0
B
Vest4
0.036
MutPred
0.087
Loss of helix (P = 0.079)
MPC
1.2
ClinPred
0.0066
T
GERP RS
3.3
Varity_R
0.084
gMVP
0.38
Mutation Taster
=63/37
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117498128; hg19: chr18-42643270; COSMIC: COSV56314036; API